News
PFE
26.00
+2.40%
0.61
Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks
Seeking Alpha · 12h ago
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
NASDAQ · 18h ago
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
Pfizer's share price has fallen about 10% since my last article on the company. The company's sales of respiratory virus vaccine Abrysvo increased 37.3% in the fourth quarter of 2023. I am upgrading Pfizer's rating from 'Buy' to 'Strong Buy' Pfizer is one of the largest pharmaceutical companies.
Seeking Alpha · 20h ago
Boost Your Dividend Income With These Two High-Yield Stocks
Seeking Alpha · 1d ago
Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value
Seeking Alpha · 1d ago
December 20th Options Now Available For Pfizer (PFE)
NASDAQ · 1d ago
Dividend Harvesting Portfolio Week 163: $16,300 Allocated, $1,458.36 In Projected Dividends
Seeking Alpha · 1d ago
ClearBridge Appreciation ESG Strategy Q1 2024 Portfolio Manager Commentary
Seeking Alpha · 1d ago
Johnson & Johnson: Buy This Bargain Before It's Gone
Seeking Alpha · 1d ago
Weight-loss drug developer Metsera raises $290 million in funding
Weight-loss drug developer Metsera raises $290 million in funding. The company is developing injectable and oral drugs to treat obesity. Multiple drug companies are competing to grab a slice of the weight-loss market. The market is estimated to reach $100 billion by the end of the decade.
Reuters · 1d ago
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
NASDAQ · 2d ago
Buy 11 MediaMade April ProActive Dividend Dogs
Seeking Alpha · 2d ago
Pfizer-Connect Biopharma deal for anti-inflammatory agent ends
Seeking Alpha · 2d ago
Wednesday's ETF with Unusual Volume: IHE
NASDAQ · 2d ago
New constituents of Goldman Sachs’ ROE growth basket
Seeking Alpha · 2d ago
ProShares Ultra S&P500 Experiences Big Outflow
NASDAQ · 2d ago
CVS favors Humira copycats hurting AbbVie’s market share: Evercore
Seeking Alpha · 2d ago
Top US markets regulator probing insider trading guardrails, official says
Top US markets regulator probing insider trading guardrails, official says. SEC is looking to crack down on ineffective policies and procedures, SEC's enforcement director says. The SEC has pursued theories of insider trading seen by many as illegal. SEC's efforts are aimed at potential use of complex financial tools to mask misconduct.
Reuters · 2d ago
3 No-Brainer Stocks to Buy With $100 Right Now
If you have $100 to invest, three stocks stand out as no-brainer buys with $100 right now. Pfizer, Philip Morris International, and tobacco giant Philip Morris are good buys for investors. Pfizers is a pharmaceutical giant that's on the right track. Philip Morris is a tobacco giant with a well-defined competitive advantage.
The Motley Fool · 2d ago
FHLC: Healthcare Dashboard For April
Seeking Alpha · 3d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.